A New Smoothened Antagonist Bearing the Purine Scaffold Shows Antitumour Activity In Vitro and In Vivo.

MLA

Zárate, Ana María, et al. “A New Smoothened Antagonist Bearing the Purine Scaffold Shows Antitumour Activity In Vitro and In Vivo.” International Journal of Molecular Sciences, vol. 22, no. 16, Aug. 2021. EBSCOhost, https://doi.org/10.3390/ijms22168372.

APA

Zárate, A. M., Espinosa-Bustos, C., Guerrero, S., Fierro, A., Oyarzún-Ampuero, F., Quest, A. F. G., Di Marcotullio, L., Loricchio, E., Caimano, M., Calcaterra, A., González-Quiroz, M., Aguirre, A., Meléndez, J., & Salas, C. O. (2021). A New Smoothened Antagonist Bearing the Purine Scaffold Shows Antitumour Activity In Vitro and In Vivo. International Journal of Molecular Sciences, 22(16). https://doi.org/10.3390/ijms22168372

Chicago

Zárate, Ana María, Christian Espinosa-Bustos, Simón Guerrero, Angélica Fierro, Felipe Oyarzún-Ampuero, Andrew F G Quest, Lucia Di Marcotullio, et al. 2021. “A New Smoothened Antagonist Bearing the Purine Scaffold Shows Antitumour Activity In Vitro and In Vivo.” International Journal of Molecular Sciences 22 (16). doi:10.3390/ijms22168372.